Allied Biotech Corporation (TPEX:1780)

Market Cap	2.29B +36.3%
Revenue (ttm)	922.49M +12.4%
Net Income	180.52M -21.3%
EPS	1.85 -21.2%
Shares Out	96.24M
PE Ratio	12.84
Forward PE	n/a
Dividend	1.25 (5.18%)
Ex-Dividend Date	Jun 4, 2026

Volume	41,600
Open	23.25
Previous Close	23.80
Day's Range	23.10 - 23.45
52-Week Range	16.80 - 36.85
Beta	0.17
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 10, 2026

About Allied Biotech

Allied Biotech Corporation engages in the manufacture and sale of carotenoids worldwide. The company’s products include Beta-Carotene that offers yellow to reddish orange shades to appeal color in various applications; Beta-Apo-8'-Carotenal, which is used as a food colorant, and provides a range of orange to red shades; and Lycopene, which offers a range of red shades as a nutrient for food, dietary supplements, and pharmaceutical products. It also provides Canthaxanthin, which offers a range of shades of reddish orange for food and beverage ap...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 40
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 1780

Financial Performance

In 2025, Allied Biotech's revenue was 849.51 million, an increase of 5.28% compared to the previous year's 806.92 million. Earnings were 129.46 million, an increase of 28.25%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 30, 2026

Data Sources Report a data error